BioTrinity 2022 will take place April 26-27, 2022 at 155 Bishopsgate in London, UK.
The BioTrinity conference aims to catalyse growth and supports in-person engagement across the life sciences industry. The event will be attended by early-stage and emerging life sciences R&D companies, investors, large pharma, and other valued partners throughout the life sciences ecosystem.
The conference features two presentation tracks. The first is focused on the latest scientific innovation across six key therapy areas: oncology, rare disease, inflammatory disease, microbiome, AI/data and platforms, CNS and infectious diseases.
The second track will address business topics pertinent to the life sciences industry including: investment, regulatory, capital markets, future trends, tax credits, clinical trials, and talent.
BioTrinity 2022 will feature pre-scheduled live and in-person private partnering meetings during the two-day physical conference as well as a third day of virtual-only partnering on Thursday 28 April 2022.
There will be a sponsors exhibition area and networking opportunities on both days, as well as an option for registered delegates to revisit recorded presentations in the days following the conference.